Skip to content

Clinical randomized controlled study of hydrolyzed formula milk in improving feeding intolerance in premature infants

Clinical randomized controlled study of hydrolyzed formula milk in improving feeding intolerance in premature infants

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100048475
Enrollment
Unknown
Registered
2021-07-09
Start date
2021-12-01
Completion date
Unknown
Last updated
2022-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

feeding intolerance in preterm infants

Interventions

control group:Extensively hydrolyzed formulas
experimental group:Amino acid-based formula

Sponsors

Children's Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Admission between December 2021 and December 2023. 2. Gestational age (GA) < 32 weeks or birth weight < 1500g, appropriate for gestational age, admitted to Department of neonatology, Children's Hospital of Chongqing Medical University within the first 24 h after birth, maximal enteral intake <50mL/kg/day. 3. Receive milk for premature infants after admission; 4. Meet the diagnostic criteria of FI; 5. Children's guardians are willing to participate in this study.

Exclusion criteria

Exclusion criteria: 1. Perinatal hypoxia; 2. History of underlying metabolic or chronic diseases, congenital malformations, or any other disease that may affect the ability to eat, normal growth and development, or participant assessment; 3. Major surgery requiring general anesthesia (except ligation of patent ductus arteriosus) was performed before or on the day of randomization; 4. Unstable blood pressure (allow 40% on the day of randomization (allowing nasal intubation and/or nasal continuous positive airway pressure (CPAP) and/or oxygen mask); 6. Diagnosis of grade III or IV intraventricular hemorrhage (IVH) before or on the day of randomization.

Design outcomes

Primary

MeasureTime frame
Time (days) to reach full eternal feedings;

Countries

China

Contacts

Public ContactLu Qi

Children's Hospital of Chongqing Medical University

qilu_qi@163.com+86 15823020185

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026